HLA class I A and B typing in the clinical laboratory using DNA-based techniques

HLA typing is essential for organ transplantation and disease association studies. Traditional serological methods have limitations in resolution and specificity. Recent advancements in DNA-based techniques have improved accuracy. However, clinical adoption of these methods remains limited. Prior research has shown that PCR-based systems can offer higher resolution than serology. Yet, validation in large clinical cohorts is lacking. This gap motivated the investigation of PCR-SSOP for HLA-A and -B typing. The study aimed to assess whether DNA-based typing could replace serology in non-urgent clinical settings.

The study aimed to evaluate the feasibility of PCR-SSOP for HLA-A and -B typing in clinical laboratories. Researchers sought to determine if DNA-based methods could match or exceed serological resolution. The primary objective was to test the PCR-SSOP system's performance on clinical samples. A secondary goal was to compare results with serology and ARMS-PCR. The study also aimed to identify subtypes and resolve ambiguous serological types. The researchers focused on improving resolution for HLA-B and HLA-A loci. They wanted to confirm whether the PCR-SSOP system could be used in routine clinical settings. The ultimate aim was to provide a validated alternative to traditional serology.

The study used PCR-SSOP to type HLA-A and -B loci in clinical samples. A total of 210 HLA-B and 100 HLA-A samples were analyzed. HLA-B typing involved two 3' primers and HLA-specific 5' primers. A panel of 30 digoxigenin-labeled SSOPs was used for HLA-B. For HLA-A, a single primer pair and 16 SSOPs were applied. ARMS-PCR was used in 25 samples to confirm results. The system was tested for resolution and accuracy. The study compared PCR-SSOP results with serological data. The approach aimed to resolve ambiguities and identify subtypes.

PCR-SSOP successfully typed all 210 HLA-B samples with high resolution. The system resolved ambiguities and confirmed serological types in 209 cases. HLA-A typing was performed on 100 samples using 16 SSOPs. The method resolved HLA-A19 subtypes and A2 homozygosity. ARMS-PCR confirmed 25 of the assigned HLA types. The PCR-SSOP system matched or exceeded serological resolution. No false negatives were reported in the HLA-B cohort. The HLA-A results showed improved specificity over traditional methods.

The PCR-SSOP system demonstrated high resolution for HLA-A and -B typing. The method matched or exceeded serological accuracy in most cases. ARMS-PCR confirmed the reliability of PCR-SSOP results. The system resolved ambiguities and identified subtypes effectively. The study suggests that PCR-SSOP is suitable for non-urgent clinical typing. The authors propose that DNA-based methods can replace serology in routine settings. The findings indicate that PCR-SSOP is a viable alternative to traditional typing. The system's performance supports its use in clinical laboratories.